Graphico

Graphico EBIT CAGR 5Y

Delisted

The EBIT CAGR (5 Year) of Graphico (4930.T) as of Nov 14, 2026 is 11.74 %. In the previous year, EBIT CAGR (5 Year) was 11.74 % — a change of 0.00% (lower).

EBIT CAGR 5Y

11.74 %

YoY

0.00%

Last updated:

EBIT CAGR (5 Year) of Graphico is 2023 11.74 % . EBIT CAGR (5 Year) of Graphico was 2022 11.74 % . It decreases by 0.00% lower compared to the previous year.

The Graphico EBIT CAGR 5Y history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT CAGR 5Y
Date
EBIT CAGR 5Y
Jan 1, 2014
11.74 JPY
Jan 1, 2015
11.74 JPY
Jan 1, 2018
11.74 JPY
Jan 1, 2019
11.74 JPY
Jan 1, 2020
11.74 JPY
Jan 1, 2021
11.74 JPY
Jan 1, 2022
11.74 JPY
Jan 1, 2023
11.74 JPY
The Graphico EBIT CAGR 5Y history
YEAREBIT CAGR 5YYoY
11.74 %0.00%
11.74 %0.00%
11.74 %0.00%
11.74 %0.00%
11.74 %0.00%
11.74 %0.00%
11.74 %0.00%
11.74 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Graphico Stock analysis

What does Graphico do? Graphico Inc. generates revenue through the sale of health foods, cosmetics, ethical drugs, over-the-counter drugs, and household products via drug stores, general merchandise stores, home centers, variety stores, and mail-order channels. The company outsources manufacturing and logistics while focusing on product planning, development, marketing, and sales. Its main product categories include healthcare centered on health foods, beauty care centered on cosmetics, and ethical and over-the-counter drugs. Overseas sales are handled through country-specific distributors. The company targets consumers seeking health and beauty solutions through established retail channels and direct mail-order services. Product planning and development are central to its strategy, with a focus on health foods, cosmetics, and pharmaceuticals. The firm operates as a fabless business model, relying on external partners for manufacturing and logistics to maintain agility in product innovation. Graphico Inc. serves multiple segments including health-conscious women, beauty care consumers, and individuals seeking over-the-counter medications. Sales channels include drug stores, GMS, home centers, variety stores, and mail-order systems. The company's overseas presence is supported by distributors in each country, enabling global market access without direct operational infrastructure. Graphico is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Graphico stock

EBIT CAGR (5 Year) of Graphico is 11.74 % in 2023.

On Eulerpool you can find the complete historical development of EBIT CAGR (5 Year) Graphico since 2006 – with annual values, charts, and detailed analysis.

The 5-year EBIT CAGR shows the compound annual growth rate of EBIT over the past five years.

To evaluate EBIT CAGR (5 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT CAGR (5 Year).

EBIT CAGR (5 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT CAGR (5 Year)'s Graphico historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Graphico

All Key Metrics — Graphico